Acquisition / mergerFiled on BSE ·
Privi Specialty Chemicals Limited submits scheme of arrangement for NSE observation
Privi Speci. · Chemicals & Petrochemicals
What the filing says
- NSE granted no objection under Regulation 37 of SEBI (LODR) Regulations, valid till Nov 04, 2026
- Scheme involves amalgamation of Privi Speciality Chemicals Limited (PSCL), Prigiv Specialties Private Limited (PFSPL), and Privi Biotechnologies Private Limited (PBPL)
- Valuation report by RBSA Valuation Advisors LLP; Fairness opinion by Vivro Financial Services Pvt Ltd; share exchange ratio based on Market and Income approaches
Original filing
Notice Of Meeting Of Equity Shareholders (Meeting) Of The Company Convened In Accordance With The Order Of The Hon'Ble National Company Law Tribunal, Mumbai Bench
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- Acquisition / mergerKothari Petrochemicals LtdKothari Petrochemicals Ltd informs NSE on NCLT order for amalgamation scheme
- Acquisition / mergerVeranda LearningVeranda Learning announces Board constitution for J.K. Shah Commerce Education Limited
- Acquisition / mergerSai Parenteral'sSai Parenterals Limited completes acquisition of 60% stake in Prathyak Laboratories
- Acquisition / mergerDr Agarwals Eye Hospital LtdDr. Agarwal’s Eye Hospital files update on Scheme of Amalgamation with Dr. Agarwal’s Health Care
- Acquisition / mergerMaithan Alloys LtdMaithan Alloys Limited acquires 2,527,000 shares of HFCL Limited on 1st Oct 2026
- Acquisition / mergerSunteck Realty LtdSunteck Realty subsidiary acquires approx. 4.5 acres land in Borivali West
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.